Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-043903
Filing Date
2025-03-24
Accepted
2025-03-24 16:33:39
Documents
1
Period of Report
2025-03-21

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 5012
  Complete submission text file 0000950170-25-043903.txt   6506
Mailing Address 14 CAMBRIDGE CENTER CAMBRIDGE MA 02142
Business Address
Hasnain Faheem (Reporting) CIK: 0001352620 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37620 | Film No.: 25764587

Mailing Address 12730 HIGH BLUFF DRIVE, SUITE 400 SAN DIEGO CA 92130
Business Address 12730 HIGH BLUFF DRIVE, SUITE 400 SAN DIEGO CA 92130 (858) 500-8800
Kura Oncology, Inc. (Issuer) CIK: 0001422143 (see all company filings)

EIN.: 611547851 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)